Alexion Highlights Promising Pipeline & Distinguished Rare Disease Capabilities at Virtual Investor DayBusiness Wire • 10/06/20
Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL AmyloidosisBusiness Wire • 09/14/20
Alexion Announces Upcoming Data Presentations at MSVirtual2020, the 8th Joint ACTRIMS – ECTRIMS MeetingBusiness Wire • 09/09/20
5 Large Biotechs and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-1924/7 Wall Street • 08/05/20